05 May, 2025

Odylia Therapeutics Announces New Pipeline Project: A Gene Replacement Therapy for NPHP1 Retinal Dystrophy

Odylia Therapeutics Welcomes Joy Cavagnaro to Board of Directors

Odylia Therapeutics is pleased to announce the appointment of Joy Cavagnaro to its Board of Directors....

12 March, 2025